Literature DB >> 2161151

Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.

M Lobigs1, R Usha, A Nestorowicz, I D Marshall, R C Weir, L Dalgarno.   

Abstract

We have passaged the prototype strain of Murray Valley encephalitis virus in SW13 (human) cells, sequenced the E and M genes, and examined the virulence of the passaged virus for 21-day-old mice following intracranial and intraperitoneal inoculation. Six independent passage series were carried out: four in the presence of mouse hyperimmune ascitic fluid and two without antibody. Changes were observed in the E protein deduced amino acid sequence for each of the six 10th passage stocks sequenced. Eleven changes were observed in total for the six stocks sequenced; these were at residues 117, 118, 390, 423, and 460. Nine of the changes were nonconservative. Five of the six passaged variants were altered at Asp 390 which is part of an Arg-Gly-Asp (RGD) sequence. This change resulted from adaptation to SW13 cells rather than from antibody selection. The RGD sequence (and residue 423) falls within a region which is highly conserved between flaviviruses and is strongly hydrophilic. All five variants which were altered at Asp 390 were attenuated in 21-day-old mice following i.p. inoculation. We propose that the domain of E encompassing the RGD sequence is an important determinant of flavivirus pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161151     DOI: 10.1016/0042-6822(90)90029-q

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Authors:  Monica A McArthur; Miguel T Suderman; John-Paul Mutebi; Shu-Yuan Xiao; Alan D T Barrett
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Cloning and sequencing of complete cDNA of Japanese encephalitis virus YL strain in Taiwan.

Authors:  J J Liu; T H Tsai; T J Chang; M L Wong
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

4.  The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization.

Authors:  F X Heinz; C W Mandl; H Holzmann; C Kunz; B A Harris; F Rey; S C Harrison
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions.

Authors:  H Holzmann; K Stiasny; H York; F Dorner; C Kunz; F X Heinz
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  PrM- and cell-binding domains of the dengue virus E protein.

Authors:  S Wang; R He; R Anderson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model.

Authors:  H Holzmann; F X Heinz; C W Mandl; F Guirakhoo; C Kunz
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.

Authors:  Eva Lee; Roy A Hall; Mario Lobigs
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.